Jiangxi Dadi Pharmaceutical Co., Ltd. has recently announced several new projects which are currently underway. These projects focus on the production of several important raw materials for pharmaceuticals and animal medicine.
Another project is the 20 ton/year Acetate Abiraterone Raw Material and Intermediate Production Project. This project, with a total investment of 50 million RMB ($7.8 million USD), will utilize unused production workshops and warehouses at the company's existing facility to build a new Acetate Abiraterone production line. This project will have an annual output of 20 tons of Acetate Abiraterone.
In conclusion, Jiangxi Dadi Pharmaceutical Co., Ltd. is investing heavily in the production of important raw materials for pharmaceutical and animal medicine. These projects represent significant advancements in the field of pharmaceutical manufacturing and demonstrate the company's commitment to improving healthcare through innovation and investment in research and development.